Sep. 4 at 5:19 PM
                            
$GMED declined 16.6% compared to the industry's 15.2% fall — but is it a hidden gem in the medical space? 💎
🔬 Strong U.S. Spine business and promising new product launches
📈 Recent Nevro acquisition unlocks a 
$2.5B market opportunity
📊 Average earnings surprise of 10.8% over the past four quarters
See if GMED's growth prospects outweigh the headwinds 👉 https://www.zacks.com/stock/news/2747332/should-you-hold-onto-globus-medical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2747332-body-11024&ADID=SYND_STOCKTWITS_TWEET_2_2747332_BODY_11024